Overview

Staccato Loxapine PK in Smokers and Nonsmokers

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The objective of this trial was to assess the pharmacokinetics of a single dose of 10 mg Staccato Loxapine administered to smokers compared to nonsmokers.

Phase:

Phase 1

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Treatments:

Loxapine